QUOTE AND NEWS
FierceBiotech  Aug 6  Comment 
The Cranbury, NJ-based biotech says they will focus on knockoffs of Humira, Rituxan, Avastin, Herceptin and Erbitux.
BusinessWeek  Oct 26  Comment 
InVentiv Health Inc., a health-care services company owned by Thomas H. Lee Partners LP, decided against making a counterbid for Pharmaceutical Product Development Inc. after it couldn’t get access to some confidential data, said people familiar...
FierceBiotech  May 18  Comment 
The CRO side of the drug development business has been consolidating at a rapid pace over the last 12 months. And inVentiv Health is helping accelerate that trend with the news that it is snapping up PharmaNet, its second buyout in just four...
Globe Newswire  Mar 1  Comment 
SOMERSET, N.J., March 1, 2011 (GLOBE NEWSWIRE) -- inVentiv Health today announced the rebranding of The Franklin Group, a leading provider of patient access and reimbursement services to the healthcare industry, as inVentiv Patient Access Solutions.
Globe Newswire  Oct 25  Comment 
SOMERSET, N.J., Oct. 25, 2010 (GLOBE NEWSWIRE) -- inVentiv Commercial, a division of inVentiv Health and the industry leader in outsourced sales teams to the pharmaceutical industry, announced today that it has been selected by international
Globe Newswire  Oct 21  Comment 
SOMERSET, N.J., Oct. 21, 2010 (GLOBE NEWSWIRE) -- Four companies within inVentiv Health were recognized with top honors at the 2010 Medical Marketing & Media Awards, held in New York City on October 12. Blue Diesel, GSW Worldwide, and Ignite Health
Globe Newswire  Sep 15  Comment 
SOMERSET, N.J., Sept. 15, 2010 (GLOBE NEWSWIRE) -- inVentiv Health, a leading provider of end-to-end clinical development, launch and commercialization services to the global healthcare industry, announced today that Joe Massaro, former Senior Vice
Globe Newswire  Sep 8  Comment 
SOMERSET, N.J., Sept. 8, 2010 (GLOBE NEWSWIRE) -- inVentiv Health, a leading provider of end-to-end clinical development, launch and commercialization services to the global healthcare industry, announced today that it has acquired Substrat'Homme SA,
Globe Newswire  Aug 4  Comment 
SOMERSET, N.J., Aug. 4, 2010 (GLOBE NEWSWIRE) -- inVentiv Health, Inc. (Nasdaq:VTIV) ("inVentiv"), a leading provider of end-to-end clinical development, launch and commercialization services to the global pharmaceutical and healthcare industries,
Globe Newswire  Aug 2  Comment 
SOMERSET, N.J., Aug. 2, 2010 (GLOBE NEWSWIRE) -- inVentiv Health (Nasdaq:VTIV), a leading provider of end-to-end clinical development, launch and commercialization services to the global pharmaceutical and healthcare industries, is pleased to





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki